Combination of Genetic and Quantitative Serological Immune Markers are Associated with Complicated Crohn’s Disease Behavior

BACKGROUND: Treatment of Crohn’s disease (CD) with biologics may alter disease progression, leading to fewer disease-related complications, but cost and adverse event profiles often limit their effective use. Tools identifying patients at high risk of complications, who would benefit the most from b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lichtenstein, Gary R., Targan, Stephan R., Dubinsky, Marla C., Rotter, Jerome I., Barken, Derren M., Princen, Fred, Carroll, Susan, Brown, Michelle, Stachelski, Jordan, Chuang, Emil, Landers, Carol J., Stempak, Joanne M., Singh, Sharat, Silverberg, Mark S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4203682/
https://ncbi.nlm.nih.gov/pubmed/21391291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ibd.21661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados